Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision metadata updated from v3.2.0 to v3.3.2 on the page history. This change affects only the system version label and not the study information or user-facing content.SummaryDifference0.1%

- Check35 days agoChange DetectedThe government funding lapse notice on the page was removed. This change does not affect core study information such as recruitment status, eligibility criteria, or study data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check49 days agoChange DetectedNew version added to the Record History (2025-09-18) reflecting updated Study Status and related details.SummaryDifference0.1%

- Check78 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference11%

- Check85 days agoChange DetectedPage update to a newer revision (v3.1.0) with removal of the old revision (v3.0.2) and added topics (Study Status Oversight Contacts/Locations IPDSharing) and a date stamp.SummaryDifference2%

- Check99 days agoChange DetectedRevision updated: v3.0.2 replaces v3.0.1, and the 'Back to Top' element was removed.SummaryDifference0.7%

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.